Table 2 Characteristics of decision analysis and systematic review of RCTs
Characteristic | N (%) |
|---|---|
DA Disease category | |
Infectious diseases | 11 (29.7) |
Cancer | 10 (27) |
Cardiovascular disease | 5 (13.5) |
Venous ailments | 3 (8.1) |
OB/GYN | 2 (5.4) |
Other | 6 (16.2) |
Pressure ulcers | 2 (2) |
Crohns disease | 1 (1) |
Obesity | 1 (1) |
Achilles Tendon Rupture | 1 (1) |
Anti-phospholipid antibody syndrome | 1 (1) |
DA intervention type | |
Medication | 21 (56) |
Surgery | 14 (38) |
Abstaining from breast feeding | 1 (3) |
Early weaning from breast feeding | 1 (3) |
DA control type | |
Medication | 18 (48.6) |
Observation | 10 (27) |
Surgery | 5 (13.5) |
Breast feeding | 2 (5.4) |
Radiation | 1 (2.7) |
Placebo | 1 (2.7) |
SR of RCTs characteristic | |
Median sample size (range) | 2610 (42–32523) |